Filing based on pivotal Phase 3 ORCA-2 and ORCA-3 clinical trials demonstrating statistically significant and clinically meaningful smoking cessation FDA acceptance starts the review process and sets ...
Achieve Life Sciences (ACHV) announced several milestones in its ORCA-OL long-term safety trial supporting the New Drug Application, NDA, review process of cytisinicline for smoking cessation. 120-Day ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback